Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib of CC-5013 and Paclitaxel in Patients With Advanced Solid Tumors

NCT01155505 is registered in ClinicalTrials.gov with Southern Europe New Drug Organization as lead sponsor.

NCT NCT01155505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01155505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib of CC-5013 and Paclitaxel in Patients With Advanced Solid Tumors
Lead sponsor
Southern Europe New Drug Organization
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2009
Completion date
March 31, 2012
Enrollment
28 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors